Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19

Clinical trial NCT04615871 · UNKNOWN

Trial details

NCT number: NCT04615871
Sponsor: Vladimír Džavík
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Covid19 Myocardial Injury

Start date: 2021-09-10
Primary completion: 2022-03-31
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.